DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundation

Hospital-acquired and ventilator-associated pneumonia

Essential points for quick revision.

!
Escalate

New pneumonia with shock, rapidly escalating oxygen or ventilatory requirements, reduced consciousness, severe sepsis, haemoptysis or suspected necrosis needs immediate senior, critical-care and microbiology input. Obtain cultures promptly when feasible, but do not delay resuscitation or time-critical antimicrobials.

Synopsis

Diagnose hospital-acquired or ventilator-associated pneumonia without mistaking colonisation or non-infective infiltrates for infection, obtain useful microbiology promptly, and start proportionate empirical therapy guided by severity and local resistance data.

  • Hospital-acquired pneumonia develops 48 hours or more after admission and was not incubating at entry; ventilator-associated pneumonia usually begins more than 48 hours after endotracheal intubation.
  • Require a compatible new clinical syndrome—fever or hypothermia, purulent secretions, inflammatory response, worsening gas exchange—and new or progressive radiographic infiltrate; no single sign proves VAP.
  • Distinguish pneumonia from atelectasis, pulmonary oedema, aspiration pneumonitis, pulmonary embolism, acute respiratory distress syndrome, alveolar haemorrhage and ventilator-associated tracheobronchitis.

Key red flags

Ventilator-associated pneumonia

New or progressive infiltrate with worsening oxygenation, increased or purulent secretions and systemic inflammatory features after more than 48 hours of invasive ventilation; rising ventilator support is a severity marker.

Investigation priorities

01
Chest radiographFirst step

Identify a new infiltrate and complications while comparing with prior films.

Management branches

First hourStabilise and establish the syndrome

Suspected HAP or VAP with new physiological deterioration.

  1. Perform ABCDE assessment, prescribe target-based oxygen, check the airway and ventilator circuit, obtain chest imaging and involve critical care early for shock or escalating support.
  2. Review admission timing, aspiration, recent procedures, fluid balance, antibiotics, prior cultures and resistance risks; search for non-pulmonary sepsis and common radiographic mimics.

Key medicines

Co-amoxiclav for low-resistance-risk HAPA typical NICE oral option is 500/125 mg three times daily for 5 days; use IV therapy if oral treatment is unsafe or severity requires it.
Piperacillin with tazobactamA common severe-infection regimen is 4.5 g IV every 8 hours, increased to every 6 hours in selected severe infection according to local policy and renal function.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom